☰

Kyriakos D. Economides, Ph.D. - Publications

Affiliations: 
2002 University of Utah, Salt Lake City, UT 
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Kamerkar S, Burzyn D, Leng C, Burenkova O, Jang SC, Yang R, Boutin A, Kirwin K, Zi T, Dahlberg W, Zhang E, Zhang K, Estes S, Economides K, Soos T, et al. Abstract A50: Reprogramming of tumor-associated M2 macrophages with antisense oligonucleotide-loaded exosomes results in potent single-agent antitumor activity Cancer Immunology Research. 8. DOI: 10.1158/2326-6074.Tumimm19-A50  0.302
2019 Dooley K, Xu K, Haupt S, Lewis N, Harrison R, Martin S, McCoy C, Sia CL, Jang SC, Kirwin K, McConnell R, Choi B, Boutin AT, Houde D, Sanchez-Salazar J, ... ... Economides KD, et al. Abstract 2150: engEx: A novel exosome engineering platform enabling targeted transfer of pharmacological molecules Cancer Research. 79: 2150-2150. DOI: 10.1158/1538-7445.Sabcs18-2150  0.315
2019 Jang SC, Moniz RJ, Sia CL, Harrison RA, Houde D, Ross N, Xu K, Lewis N, Bourdeau R, McCoy C, Zi T, Villiger-Oberbek A, Estes S, Sanchez-Salazar J, Dooley K, ... ... Economides KD, et al. Abstract 944: exoSTING: An engineered exosome therapeutic that selectively delivers STING agonist to the tumor resident antigen-presenting cells resulting in improved tumor antigen-specific adaptive immune response Cancer Research. 79: 944-944. DOI: 10.1158/1538-7445.Am2019-944  0.316
2018 Vohidov F, Andersen JN, Economides KD, Shipitsin MV, Burenkova O, Gallagher NM, Sheih P, Golder M, Liu J, Dahlberg WK, Nguyen HV, Ehrlich DJ, Kim J, Huh SJ, Vangamudi B, et al. Abstract LB-062: Development of macromolecular prodrugs of BET-bromodomain inhibitors with superior anti-tumor efficacy that are T-cell sparing and devoid of systemic toxicity Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-Lb-062  0.307
2011 Pang Z, Wu NN, Zhao W, Chain DC, Schaffer E, Zhang X, Yamdagni P, Palejwala VA, Fan C, Favara SG, Dressler HM, Economides KD, Weinstock D, Cavallo JS, Naimi S, et al. The central cannabinoid CB1 receptor is required for diet-induced obesity and rimonabant's antiobesity effects in mice. Obesity (Silver Spring, Md.). 19: 1923-34. PMID 21799481 DOI: 10.1038/Oby.2011.250  0.337
2009 Wang X, Kruithof-de Julio M, Economides KD, Walker D, Yu H, Halili MV, Hu YP, Price SM, Abate-Shen C, Shen MM. A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature. 461: 495-500. PMID 19741607 DOI: 10.1038/Nature08361  0.389
2008 Shen MM, Wang X, Economides KD, Walker D, Abate-Shen C. Progenitor cells for the prostate epithelium: roles in development, regeneration, and cancer. Cold Spring Harbor Symposia On Quantitative Biology. 73: 529-38. PMID 19150960 DOI: 10.1101/Sqb.2008.73.050  0.378
2003 Economides KD, Zeltser L, Capecchi MR. Hoxb13 mutations cause overgrowth of caudal spinal cord and tail vertebrae. Developmental Biology. 256: 317-30. PMID 12679105 DOI: 10.1016/S0012-1606(02)00137-9  0.457
2003 Economides KD, Capecchi MR. Hoxb13 is required for normal differentiation and secretory function of the ventral prostate. Development (Cambridge, England). 130: 2061-9. PMID 12668621 DOI: 10.1242/Dev.00432  0.457
Show low-probability matches.